SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-24-047861
Filing Date
2024-05-30
Accepted
2024-05-30 14:15:42
Documents
6
Period of Report
2024-07-16

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ea0206994-def14a_60degrees.htm DEF 14A 552685
2 GRAPHIC image_001.jpg GRAPHIC 5048
3 GRAPHIC image_002.jpg GRAPHIC 5048
4 GRAPHIC image_003.jpg GRAPHIC 747869
5 GRAPHIC image_004.jpg GRAPHIC 744341
6 GRAPHIC image_005.jpg GRAPHIC 803990
  Complete submission text file 0001213900-24-047861.txt   3730445
Mailing Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036
Business Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036 202-327-5422
60 DEGREES PHARMACEUTICALS, INC. (Filer) CIK: 0001946563 (see all company filings)

IRS No.: 452406880 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41719 | Film No.: 241003938
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)